News

Weekly Policy Update: End the Device Tax

Friday, August 09, 2019

 

Weekly Policy Update: HHS and FDA Announce Plan to Allow Importation of Prescription Drugs

Friday, August 02, 2019


 

Zoetis Establishes Research Lab At CSU To Explore Immunotherapies For Livestock

Tuesday, July 30, 2019

Zoetis, the world’s leading animal health company, has signed an agreement with Colorado State University to establish a research lab at CSU that will explore the livestock immune system and target new immunotherapies – paving the way for new alternatives to antibiotics in food-producing animals. The new 3,000-square-foot Zoetis Incubator Research Lab will operate at the Research Innovation Center on CSU’s Foothills Campus starting in early 2020.

Read the full story at the Colorado State University's Source.

 
Continue Reading

Weekly Policy Update: Senate Finance Committee Advances Drug Pricing Package

Friday, July 26, 2019

On Thursday, the Senate Finance Committee advanced a major legislative package that includes substantial changes to Medicare and Medicaid drug reimbursement. The bill, the Prescription Drug Pricing Reduction Act, passed the Committee by a vote of 19-9 and will be considered by the full Senate in the fall. 

Agilent Announces Purchase of Boulder Facility

Thursday, July 25, 2019

Agilent Technologies has announced it is purchasing the building in Boulder where they have been manufacturing therapeutic oligonucleotides (“oligos") for over a decade. This $12 million purchase, along with their recent $150 million investment in their second oligo manufacturing site in Frederick, Colorado, more than doubles their capacity to produce oligos and reaffirms Agilent’s confidence in the therapeutic oligo market. Furthermore, it solidifies their commitment to doing business in the state of Colorado and their commitment to be a good corporate citizen in local communities.  

2019 Rocky Mountain Life Science Investor and Partnering Conference Announces Presenting Companies

Wednesday, July 24, 2019

September conference led by Colorado BioScience Association to provide companies from across the region new opportunities for capital access 
Continue Reading

Weekly Policy Update: We Work For Health Summit—CBSA Urges Federal Lawmakers to Promote Medical Innovation and Protect Patient Access

Monday, July 22, 2019

 

Viewray to Expand to Denver, Adding 274 Jobs

Tuesday, July 16, 2019

Viewray, Inc., an Ohio-based medical technology company that provides high-level MRI-guided radiation technology is expanding its operations in the metro Denver area and will be hiring 274 people over the next eight years.

Read the full story on the Denver Business Journal’s website.

 
Continue Reading

Weekly Policy Update: Trump Administration Pulls Rebate Rule

Monday, July 15, 2019

Last week the Trump Administration withdrew their proposed rebate rule that would have required manufacturer rebates to be passed through to patients in Part D and other government programs.  

Silvergate Pharmaceuticals Merges With CutisPharma To Serve Patients On Opposite Ends of the Spectrum

Wednesday, July 10, 2019

Silvergate Pharmaceuticals produces pediatric medications, while CutisPharma has served the senior population. They’re bringing their companies together to form Azurity Pharmaceuticals.

While it might initially seem like the two patient groups have little in common, Azurity’s CEO Neal Muni believes joining forces was a very natural move. Both populations often require specialized dosing and may struggle with swallowing pills.

“It made a lot of sense strategically to better serve our patients,” Muni said. “We started talking with Silvergate and their investors quite some time back about the potential opportunity to combine the two companies. With this combination of the two we can reaffirm our commitment to the same patient populations with much larger capability.”

Read the full article on the Denver Business Journal’s website.

 
Continue Reading